Ventriculoperitoneal shunt for tuberculous meningitis-associated hydrocephalus: long-term outcomes and complications.
Complications
Hydrocephalus
Tuberculous meningitis
Ventriculoperitoneal Shunt
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
30 Oct 2023
30 Oct 2023
Historique:
received:
25
05
2023
accepted:
02
10
2023
medline:
2
11
2023
pubmed:
31
10
2023
entrez:
31
10
2023
Statut:
epublish
Résumé
Hydrocephalus is a frequent complication of tuberculous meningitis (TBM), and ventriculoperitoneal shunt (VPS) has been shown to improve short-term prognosis for patients with TBM-associated hydrocephalus. However, questions remain about long-term prognosis and shunt-related complications. This study aims to provide a comprehensive assessment of both long-term prognosis and shunt-related complications in patients with TBM-induced hydrocephalus who have undergone VPS treatment. This retrospective study analyzed the clinical data of TBM patients with hydrocephalus treated with VPS at Peking Union Medical College Hospital between December 1999 and February 2023. Both short-term outcomes at discharge and long-term outcomes during follow-up were examined. Prognosis and shunt-related complications were assessed using the modified Rankin Scale (mRS) and the Activity of Daily Living (ADL) score to evaluate neurological function and autonomic living ability, respectively. A total of 14 patients with TBM-associated hydrocephalus were included in this study. Of these, 92.9% (13/14) exhibited favorable short-term outcomes, while 57.1% (8/14) showed positive long-term outcomes. Initial results indicated 6 complete recoveries (CR), 7 partial recoveries (PR), and 1 treatment failure. No catheter-related complications were observed initially. Long-term results included 4 CRs, 4 PRs, and 6 treatment failures. A variety of shunt surgery-related complications were noted, including three instances of catheter obstruction, one of incision infection, one of catheter-related infection, one of acute cerebral infarction, and one of transient peritoneal irritation accompanied by diarrhea. VPS appears to be an effective and well-tolerated treatment for TBM-associated hydrocephalus, efficiently alleviating acute intracranial hypertension. Nonetheless, continuous long-term monitoring and proactive management are essential to mitigate the risk of catheter-related complications.
Sections du résumé
BACKGROUND
BACKGROUND
Hydrocephalus is a frequent complication of tuberculous meningitis (TBM), and ventriculoperitoneal shunt (VPS) has been shown to improve short-term prognosis for patients with TBM-associated hydrocephalus. However, questions remain about long-term prognosis and shunt-related complications. This study aims to provide a comprehensive assessment of both long-term prognosis and shunt-related complications in patients with TBM-induced hydrocephalus who have undergone VPS treatment.
METHODS
METHODS
This retrospective study analyzed the clinical data of TBM patients with hydrocephalus treated with VPS at Peking Union Medical College Hospital between December 1999 and February 2023. Both short-term outcomes at discharge and long-term outcomes during follow-up were examined. Prognosis and shunt-related complications were assessed using the modified Rankin Scale (mRS) and the Activity of Daily Living (ADL) score to evaluate neurological function and autonomic living ability, respectively.
RESULTS
RESULTS
A total of 14 patients with TBM-associated hydrocephalus were included in this study. Of these, 92.9% (13/14) exhibited favorable short-term outcomes, while 57.1% (8/14) showed positive long-term outcomes. Initial results indicated 6 complete recoveries (CR), 7 partial recoveries (PR), and 1 treatment failure. No catheter-related complications were observed initially. Long-term results included 4 CRs, 4 PRs, and 6 treatment failures. A variety of shunt surgery-related complications were noted, including three instances of catheter obstruction, one of incision infection, one of catheter-related infection, one of acute cerebral infarction, and one of transient peritoneal irritation accompanied by diarrhea.
CONCLUSIONS
CONCLUSIONS
VPS appears to be an effective and well-tolerated treatment for TBM-associated hydrocephalus, efficiently alleviating acute intracranial hypertension. Nonetheless, continuous long-term monitoring and proactive management are essential to mitigate the risk of catheter-related complications.
Identifiants
pubmed: 37904093
doi: 10.1186/s12879-023-08661-7
pii: 10.1186/s12879-023-08661-7
pmc: PMC10614362
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
742Subventions
Organisme : Beijing Tianjin Hebei basic research cooperation project
ID : 19JCZDJC64600(Z)
Organisme : National Key R&D Program of China
ID : 2018YFA0108603
Organisme : National High Level Hospital Clinical Research Funding
ID : 2022-PUMCH-C-032
Informations de copyright
© 2023. The Author(s).
Références
Neurol India. 2021 Nov-Dec;69(Supplement):S330-S335
pubmed: 35102984
Lancet Neurol. 2013 Oct;12(10):999-1010
pubmed: 23972913
Childs Nerv Syst. 2021 Nov;37(11):3397-3406
pubmed: 34148129
Childs Nerv Syst. 2012 Feb;28(2):209-15
pubmed: 21909965
Malawi Med J. 2013 Sep;25(3):78-82
pubmed: 24358424
Tuberculosis (Edinb). 2010 Nov;90(6):393-400
pubmed: 20970381
BMC Infect Dis. 2020 May 1;20(1):318
pubmed: 32357835
Nat Rev Neurol. 2017 Oct;13(10):581-598
pubmed: 28884751
Int J Tuberc Lung Dis. 2018 Jul 1;22(7):788-792
pubmed: 29914605
Emerg Infect Dis. 2022 Mar;28(3):660-671
pubmed: 35202524
Sci Rep. 2021 Apr 21;11(1):8654
pubmed: 33883576
Lancet Infect Dis. 2010 Nov;10(11):803-12
pubmed: 20822958
N Engl J Med. 2016 Jan 14;374(2):124-34
pubmed: 26760084
Lancet Infect Dis. 2014 Oct;14(10):947-57
pubmed: 25108337
Br J Neurosurg. 2001 Apr;15(2):119-25
pubmed: 11360374
Front Neurol. 2022 Nov 17;13:773334
pubmed: 36468057
PLoS One. 2023 Feb 16;18(2):e0279203
pubmed: 36795648
Indian J Tuberc. 2011 Apr;58(2):77-81
pubmed: 21644394
Cureus. 2022 May 25;14(5):e25317
pubmed: 35637922
BMC Neurol. 2021 Aug 10;21(1):308
pubmed: 34376174
J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):115-8
pubmed: 9667572
Lancet Neurol. 2019 Aug;18(8):771-783
pubmed: 31109897
J Neurosurg. 2015 May;122(5):1087-95
pubmed: 25679277